Related Experiment Video
Updated: Jul 4, 2025
12:01
Detection of Disease-associated α-synuclein by Enhanced ELISA in the Brain of Transgenic Mice Overexpressing Human A53T Mutated α-synuclein
Published on: May 30, 2015
10.7K
Pathological α-synuclein detected by real-time quaking-induced conversion in synucleinopathies
Juan Huang1, Xingxing Yuan2, Lin Chen1
1Department of Neurology, Second Affiliated Hospital of Nanchang University, Jiangxi Medical College, Nanchang University, China.
Experimental Gerontology
|January 27, 2024
Summary
Alpha-synuclein (α-syn) seed amplification assays (SAAs) detect misfolded α-syn aggregates in synucleinopathies. The alpha-synuclein real-time quaking-induced conversion (α-Syn RT-QuIC) assay shows high accuracy for diagnosing Parkinson
Area of Science:
- Neuroscience
- Biochemistry
- Medical Diagnostics
Background:
- Synucleinopathies are neurodegenerative diseases defined by alpha-synuclein (α-syn) aggregation.
- Current diagnostic methods often lack sensitivity for early-stage detection of pathological α-syn.
Approach:
- Review of the development and advancements of alpha-synuclein seed amplification assays (SAAs).
- Detailed examination of the alpha-synuclein real-time quaking-induced conversion (α-Syn RT-QuIC) assay.
- Exploration of α-syn detection in various biospecimens like CSF, skin, and serum.
Key Points:
- α-Syn RT-QuIC demonstrates high sensitivity and specificity for detecting pathological α-syn in Parkinson's disease (PD) and dementia with Lewy bodies (DLB).
- The assay achieves up to 80% accuracy in diagnosing PD and DLB.
- Kinetic thioflavin T (ThT) parameters enable differential diagnosis between DLB, PD, and multiple system atrophy (MSA).
- Detection of α-syn in prodromal stages allows for early intervention.
Conclusions:
- The α-Syn RT-QuIC assay represents a significant advancement in diagnosing and managing synucleinopathies.
- This assay facilitates early detection and differential diagnosis, improving patient outcomes.
- Continued research and application of α-Syn RT-QuIC are crucial for combating synucleinopathies.
